Valeant Pharmaceuticals (NYSE: VRX) is the perfect example of everything that's wrong with the markets today.
In just one company, you find...
A risky, predatory, and destructive business model; extremely shady, allegedly illegal accounting and operating practices; $30 billion of debt on just $9 billion in the trailing 12 months; the most enthusiastic sell-side analysts money can buy; a huge number of investors who didn't realize they were exposed to this mess; and several hedge fund managers who should've known better...
Back in October 2015, when I realized how far and how fast this company's fall was going to be, I made the only recommendation I could in that situation:
Make a killing on Valeant's spectacular demise.
Now, Valeant is likely doomed as a company, and it's time to wind down this short-side profit play - with the gains we've had, there's no reason to chase it down any further. I'd like to see it fall further, personally, because it's a disgusting company, but there's no need to be greedy.
The very good news is there are plenty of other companies out there like it right now. In fact, I'm tracking one as I write this.